Page last updated: 2024-09-04

isoflavanone and Adrenocortical Carcinoma

isoflavanone has been researched along with Adrenocortical Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gayer, B; Knoll, E; Kohen, F; Kulik, T; Sharon, O; Somjen, D; Stern, N1

Other Studies

1 other study(ies) available for isoflavanone and Adrenocortical Carcinoma

ArticleYear
Carboxy derivatives of isoflavones as affinity carriers for cytotoxic drug targeting in adrenocortical H295R carcinoma cells.
    The Journal of endocrinology, 2003, Volume: 179, Issue:3

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Antibiotics, Antineoplastic; Cell Survival; Creatine Kinase; Daunorubicin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Estrogens; Female; Humans; Isoflavones; Neoplasm Proteins; Rats; Rats, Wistar; Receptors, Estrogen; Transcription, Genetic; Tumor Cells, Cultured

2003